From October 1, 2023 to December 31, 2023, the company has repurchased 1,385,217 shares, representing 4.19% for $25 million. With this, the company has completed the repurchase of 3,088,069 shares, representing 9.09% for $75 million under the buyback announced on January 4, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.42 USD | +1.62% | +4.54% | +18.32% |
Apr. 11 | Collegium Pharmaceutical to Redeem $26.35 Million of Senior Notes | MT |
Feb. 26 | Piper Sandler Adjusts Price Target on Collegium Pharmaceutical to $39 From $37, Maintains Overweight Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.32% | 1.19B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- COLL Stock
- News Collegium Pharmaceutical, Inc.
- Tranche Update on Collegium Pharmaceutical, Inc.'s Equity Buyback Plan announced on January 4, 2023.